Victoria Wykes

Dr. Victoria Wykes

Institute of Cancer and Genomics, University of Birmingham, Birmingham, UK
+1
orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2020 in Insights into Imaging
Verified
Journal Article
Open access
PDF file
VSVijay Sawlani
Vijay Sawlani
MPMarkand Dipankumar Patel
Markand Dipankumar Patel
NDNigel Davies
Nigel Davies
RFRobert Flintham
Robert Flintham
RWRoman Wesolowski
Roman Wesolowski
HPHarish Poptani
Harish Poptani
MRI has a vital role in the assessment of intracranial lesions. Conventional MRI has limited specificity and multiparametric MRI using diffusion-weighted imaging, perfusion-weighted imaging and magnetic resonance spectroscopy allows more accurate assessment of the tissue microenvironment. The purpose of this educational pictorial review is to demonstrate the role of multiparametric MRI for diagnosis, treatment planning and for assessing treatment response, as well as providing a practical approach for performing and interpreting multiparametric MRI in the clinical setting. A variety of cases are presented to demonstrate how multiparametric MRI can help differentiate neoplastic from non-neoplastic lesions compared to conventional MRI alone.

Verified
Journal Article
Open access
PDF file
AFAlina Finch
Alina Finch
GSGeorgios Solomou
Georgios Solomou
VWVictoria Wykes
Victoria Wykes
UPUte Pohl
Ute Pohl
CBChiara Bardella
Chiara Bardella
CWColin Watts
Colin Watts
Diffuse gliomas are the most frequent brain tumours, representing 75% of all primary malignant brain tumours in adults. Because of their locally aggressive behaviour and the fact that they cannot be cured by current therapies, they represent one of the most devastating cancers. The present review summarises recent advances in our understanding of glioma development and progression by use of various in vitro and in vivo models, as well as more complex techniques including cultures of 3D organoids and organotypic slices. We discuss the progress that has been made in understanding glioma heterogeneity, alteration in gene expression and DNA methylation, as well as advances in various in silico models. Lastly current treatment options and future clinical trials, which aim to improve early diagnosis and disease monitoring, are also discussed.

5 May 2012 in Child's Nervous System
Verified
Journal Article
Closed access
PDF file
VWVictoria Wykes
Victoria Wykes
DDDivyesh Desai
Divyesh Desai
DTDominic N. P. Thompson
Dominic N. P. Thompson

1 December 2003 in Molecular Pharmacology
Verified
Journal Article
Closed access
PDF file
CGCharmaine Griffiths
Charmaine Griffiths
VWVictoria Wykes
Victoria Wykes
TBTomas C. Bellamy
Tomas C. Bellamy
JGJohn Garthwaite
John Garthwaite
The signaling molecule nitric oxide (NO) could engage multiple pathways to influence cellular function. Unraveling their relative biological importance has been difficult because it has not been possible to administer NO under the steady-state conditions that are normally axiomatic for analyzing ligand-receptor interactions and downstream signal transduction. To address this problem, we devised a chemical method for generating constant NO concentrations, derived from balancing NO release from a NONOate donor with NO consumption by a sink. On theoretical grounds, 2-4-carboxyphenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (CPTIO) was selected as the sink. The mixture additionally contained urate to convert an unwanted product of the reaction (NO2) into nitrite ions. The method enabled NO concentrations covering the physiological range (0-100 nM) to be formed within approximately 1 s. Moreover, the concentrations were sufficiently stable over at least several minutes to be useful for biological purposes. When applied to the activation of guanylyl cyclase-coupled NO receptors, the method gave an EC50 of 1.7 nM NO for the protein purified from bovine lung, which is lower than estimated previously using a biological NO sink (red blood cells). The corresponding values for the α1β1 and α2β1 isoforms were 0.9 nM and 0.5 nM, respectively. The slopes of the concentration-response curves were more shallow than before (Hill coefficient of 1 rather than 2), questioning the need to consider the binding of more than one NO molecule for receptor activation. The discrepancies are ascribable to limitations of the earlier method. Other biological problems can readily be addressed by adaptations of the new method.

13 October 2020 in Journal of Neurological Surgery Part A: Central European Neurosurgery
Verified
Journal Article
Closed access
PDF file
VWVictoria Wykes
Victoria Wykes
AZAthanasios Zisakis
Athanasios Zisakis
MIMihaela Irimia
Mihaela Irimia
IUIsmail Ughratdar
Ismail Ughratdar
VSVijay Sawlani
Vijay Sawlani
CWColin Watts
Colin Watts
Maximal safe resection is an essential part of the multidisciplinary care of patients with glioblastoma. A growing body of data shows that gross total resection is an independent prognostic factor associated with improved clinical outcome. The relationship between extent of glioblastoma (GB) resection and clinical benefit depends critically on the balance between cytoreduction and avoiding neurologic morbidity. The definition of the extent of tumor resection, how this is best measured pre- and postoperatively, and its relation to volume of residual tumor is still discussed. We review the literature supporting extent of resection in GB, highlighting the importance of a standardized definition and measurement of extent of resection to allow greater collaboration in research projects and trials. Recent developments in neurosurgical techniques and technologies focused on maximizing extent of resection and safety are discussed.

1 July 2003 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
BGBarry J Gibb
Barry J Gibb
VWVictoria Wykes
Victoria Wykes
JGJohn Garthwaite
John Garthwaite
Physiological nitric oxide (NO) signal transduction occurs through activation of guanylyl cyclase (GC)‐coupled receptors, resulting in cGMP accumulation. There are five possible receptors: four heterodimers (α1β1, α2β1, α1β2, α2β2) and a presumed homodimer (νβ2). The present study investigated the kinetic and pharmacological properties of all these putative receptors expressed in COS‐7 (or HeLa) cells. All exhibited NO‐activated GC activity, that of α1β1 and α2β1 being much higher than that of the β2‐containing heterodimers or νβ2. All were highly sensitive NO detectors. Using clamped NO concentrations, EC50 values were 1 nM for α1β1 and 2 nM for α2β1. With α1β2, α2β2 and νβ2, the EC50 was estimated to be lower, about 8 nM. All the GCs displayed a marked desensitising profile of activity. Consistent with this property, the concentration–response curves were bell‐shaped, particularly those of the β2 heterodimers and νβ2. Confocal microscopy of cells transfected with the fluorescently tagged β2 subunit suggested targeting to the endoplasmic reticulum through its isoprenylation sequence, but no associated particulate GC activity was detected. The NO‐stimulated GC activity of all heterodimers and νβ2 was inhibited by 1H‐[1,2,4]oxadiazolo[4,3‐a]quinoxalin‐1‐one and, except for νβ2, was enhanced by the allosteric activator YC‐1. It is concluded that all the four possible heterodimers, as well as the putative νβ2 homodimer, can function as high‐affinity GC‐coupled NO receptors when expressed in cells. They exhibit differences in NO potency, maximal GC activity, desensitisation kinetics and possibly subcellular location but, except for νβ2, cannot be differentiated using existing pharmacological agents. British Journal of Pharmacology (2003) 139, 1032–1040. doi:10.1038/sj.bjp.0705318